Novo Nordisk A/S ADR buy skatcup
Start price
11.05.26
/
80%
€39.70
Target price
11.05.27
€60.00
Performance (%)
10.73%
Price
14:33
€43.96
Summary
This prediction is currently active. The prediction currently has a performance of 10.73%. This prediction currently runs until 11.05.27. The prediction end date can be changed by skatcup at any time. skatcup has 80% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novo Nordisk A/S ADR | 0.506% | 0.506% |
| iShares Core DAX® | 2.992% | 3.220% |
| iShares Nasdaq 100 | -1.584% | -3.172% |
| iShares Nikkei 225® | -2.254% | -9.924% |
| iShares S&P 500 | -0.009% | 1.641% |
According to skatcup what are the pros and cons of Novo Nordisk A/S ADR for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Standard Investments for future growth
Valuable balance sheet
ROE higher than 10% per year
Differentiated customer and product portfolio
Top 10 in its market
Small cyclical dependencies
Well known brand
EBIT growth >5% per year expected
Very Future proof/growth oriented business model
Undervalued
Good rating
Normal challenges to pay loans and raise capital
Capable Management
Innovative
Some uniques
Cons
Higher risks for its business
Comments by skatcup for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Stopped prediction by skatcup for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€44.80
10.08.25
10.08.25
€70.00
10.08.26
10.08.26
5.47%
16.08.25
16.08.25
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€66.50
07.06.25
07.06.25
€100.00
07.06.26
07.06.26
-3.76%
21.06.25
21.06.25